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Helicobacter pylori, a common human
bacterial pathogen (1), causes peptic ulcer
disease, gastric cancer, and gastric mucosa-
associated lymphoid tissue lymphoma. Current
U.S. guidelines from the National Institutes of
Health recommend antimicrobial treatment
only  for  H. pylori patients with peptic ulcer
disease (2). Because asymptomatic infection is
very common, treatment of all asymptomatic
persons would be expensive and might promote
antibiotic resistance. Prophylactic and therapeu-
tic vaccines against H. pylori are being developed
(3,4); however, if vaccines are to be cost-effective,
companies must take into account the changing
epidemiology of H. pylori and related diseases.
Knowledge of these trends can also allow health
agencies to predict resource allocations needed
for these diseases.
In industrialized countries, H. pylori incidence
has been decreasing in successive generations,
without any targeted intervention (5-7).
Quantifying the benefits of intervention in
reducing disease incidence or cost requires an
analytical model that estimates the natural
course of H. pylori and associated diseases. The
model could then estimate the decrease in
H. pylori incidence that would result from an
intervention strategy, relative to the natural
course of infection.
We present an analytical framework to model
H. pylori transmission dynamics and its
subsequent disease progression. Our goal is to
estimate future trends of H. pylori and associated
diseases in the United States based solely on its




Our analysis is based on a dynamic
compartmental model, a technique in which the
population is divided into compartments and
mathematical equations describe the transfer of
persons from one compartment to another (8). In
this technique, the incidence of H. pylori infection
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To assess the benefits of intervention programs against Helicobacter pylori
infection, we estimated the baseline curves of its incidence and prevalence. We
developed a mathematical (compartmental) model of the intrinsic dynamics of H. pylori,
which represents the natural history of infection and disease progression. Our model
divided the population according to age, infection status, and clinical state. Case-
patients were followed from birth to death. A proportion of the population acquired H.
pylori infection and became ill with gastritis, duodenal ulcer, chronic atrophic gastritis, or
gastric cancer. We simulated the change in transmissibility consistent with the incidence
of gastric cancer and duodenal ulcer over time, as well as current H. pylori prevalence.
In the United States, transmissibility of H. pylori has decreased to values so low that,
should this trend continue, the organism will disappear from the population without
targeted intervention; this process, however, will take more than a century.Vol. 6, No. 3, May–June 2000 Emerging Infectious Diseases 229 229 229 229 229
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Figure 1. Compartmental model of Helicobacter pylori transmission and disease progression. In this model, the
population is divided into compartments according to age, infection status, and clinical state. Boxes represent
population subgroups and arrows indicate transitions between subgroups, as well as flow into and out of the
population (birth and death).
is calculated as a function of the number of
susceptible and infected persons in the popula-
tion and a constant called the transmission
parameter (ß). We sought transmission param-
eters that would best explain historical trends
and allow estimates of future trends of H. pylori
prevalence and the incidence of H. pylori–
associated gastric cancer (GC) and duodenal
ulcer (DU).
We developed a compartmental model that
captures the age-dependence of H. pylori
infection and disease progression in infected
persons (Figure 1)(6,9-17). The population was
compartmentalized according to three factors:Emerging Infectious Diseases Vol. 6, No. 3, May–June 2000 230 230 230 230 230
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Table. Input variables and sources
Symbol Description Value Explanation Source
Population parameters Population parameters Population parameters Population parameters Population parameters
µ_(a) Death rate (per person per year) Age-specific        18
Z Population size (persons)   200,000 Assumption
II Birth rate (persons per year)      2,962 Derived from disease-free
  equilibrium simulation
pI Proportion (%) nonsusceptible         20 Based on data from Assumption
  developing countries
Disease parameters Disease parameters Disease parameters Disease parameters Disease parameters
pC Proportion (%) of children with          5 Assumption
 antrum (vs. corpus) gastritis
pY Proportion (%) of youths with         75 Based on simulation Assumption
  antrum (vs. corpus) gastritis
pA Proportion (%) of adults with         95 Assumption
  antrum (vs. corpus) gastritis
δ 1C AGC to CGC (per person per year)          0 Assumption
___δ 1Y AGY to CGY (per person per year)          0 Assumption
___δ 1A AGA to CGA (per person per year)    0.0010 1% progression in 10 yrs Assumption
δ 2 AGA to DU (per person per year)    0.0046 14% progression in 32 yrs        22
___δ 3 DU to CAG (per person per year)    0.0020 2% progression in 10 yrs        15
___δ 4 CGA to CAG (per person per year)    0.0112 30% progression in 32 yrs        22
___δ 5 CAG to GC (per person per year)    0.0030 3% progression in 10 yrs        13
___µDU Mortality rate due to DU    0.0050        23
  (per person per year)
___µGU Mortality rate due to GU    0.0100        24
  (per person per year)
___µGC Mortality rate due to GC    0.3219 80% death in 5 yrs        25
  (per person per year)
GC = Gastric cancer; DU = Duodenal ulcer; CG = Corpus-predominant gastritis; AG = Antrum-predominant gastritis;
CAG = Chronic atrophic gastritis.
age (child [4 years old], youth [5 to 14 years old],
and adult [>15 years old]); infection state
(uninfected and infected); and clinical state
(normal stomach, antrum-predominant gastritis,
corpus-predominant gastritis, DU, chronic atro-
phic gastritis [CAG], and GC) (Appendix). DU
and GC states corresponded to persons whose
illnesses were caused by H. pylori infection
(H. pylori–associated DU and GC). We excluded
from our model DU and GC not related to
H. pylori. Computer simulation was used to solve
the system of equations numerically and
calculate the number of persons in each
compartment over time.
We modeled the possibility of being born
susceptible or not susceptible to H. pylori
(Figure 1). The nonsusceptible or “isolated” group
comprised persons who could not become infected
for physiologic, physical, or immunologic rea-
sons. This conforms with epidemiologic studies
indicating that, even within populations at high
risk, a small percentage (10% to 20%) does not
become infected with H. pylori (9,10).
A susceptible person could become infected
with H. pylori at any age and either antrum- or
corpus-predominant gastritis could develop. The
model represents the net flow from one clinical
state to the other. Thus, we represented a
positive flow from antrum gastritis to corpus
gastritis because this progression is much larger
than the reverse. From the gastritis states, we
modeled the possibility of further clinical
progression to DU, CAG, and GC. The model is
consistent with previously reported outcomes in
that persons with antrum-predominant gastritis
are at higher risk for DU, while those who have
corpus-predominant gastritis are at higher risk
for CAG, GU, and GC (11,12-17). We also
incorporated the possibility of CAG and GC
developing in DU patients.
Input Data and Sources
Input assumptions are divided into disease
and population parameters (Table). We adopted a
constant demographic characteristic of birth and
death rates, to eliminate complexities associatedVol. 6, No. 3, May–June 2000 Emerging Infectious Diseases 231 231 231 231 231
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with changing demographics (8). Baseline
demographics were characteristic of the general
U.S. population in 1950. The age-specific death
rates from all causes were derived from the
survival curve of the Vital Statistics Report (18).
We assumed an initial population of 200,000,
which corresponds to the population of a medium-
sized city in the United States (19). The birth rate
was set so that the size of the population
remained constant when H. pylori–associated
diseases were not present. This birth rate was
derived from a disease-free simulation exercise in
which we assumed zero infection with H. pylori.
The proportion of isolated (nonsusceptible)
persons in the population, pI, is an assumption
based on data from developing countries, in
which the prevalence of H. pylori among adults
achieves an asymptote of approximately 80% by
age 30 (1,20). We assumed that earlier
acquisition of H. pylori is associated with
development of corpus-predominant gastritis
and subsequent CAG, GU, and GC, and that
acquisition at older ages is more likely to lead to
antrum-predominant gastritis and subsequent
DU (11,12,21). Therefore, we adopted 5% and
95% for the proportions of gastritis initially
restricted to the antrum in children and adults,
respectively. We chose 75% as the proportion of
antrum gastritis in youths; this estimation had to
be closer to that of adults than to that of children
for the delay of Hp acquisition to result in more
persons with antrum-predominant gastritis and
subsequent DU.
We derived the rates of clinical progression
from gastritis to cancer from published informa-
tion (13,15,22-25). The model also incorporated
deaths from DU, GU, and GC. GU is not an
explicit compartment in our model; instead, we
modeled the possibility that a person with CAG
would die of GU, in accordance with previous
studies that documented an increased risk for
GU in persons with CAG (12,16).
Transmission Parameters, Validation
of the Model, and Future Trends
We calculated incidence as a function of the
number of susceptible and infected persons in the
population and the transmission parameter, ß,
which is a constant that characterizes infectivity
of the pathogen. The number of infected persons
at each period was determined by adding the
number of persons with antrum- and corpus-
predominant gastritis, DU, and CAG. We
multiplied the number of CAG patients by a
factor   (<1), to reflect the fact that the infection
may subside (or H. pylori density may be lower)
as a result of atrophy (26), and therefore would
contribute less to the transmission of H. pylori.
Furthermore, we assumed that the role of GC
patients as a source of infection was negligible.
ß may differ according to the population, age
of infective and susceptible persons, environmen-
tal conditions, household sanitary and hygiene
practices, and genetic characteristics of the
organism itself (e.g., strain differences). Direct
measurement of ß is not possible for most
infections (8). However, the value of ß and its
change over time must be estimated to assess the
impact of public health programs against H. pylori.
Since the incidence and prevalence of H. pylori
have been decreasing in the absence of a vaccine
(which would decrease the number of susceptible
persons) or widespread eradication therapies
(which would decrease the number of infected
persons), the historical decrease in H. pylori
incidence must represent a decrease in ß. Thus,
we estimated the value of ß in the 19th century by
simulating an endemic equilibrium condition of
H. pylori in the U.S. population. We then estimated
the change in ß that would account for the
observed patterns of DU and GC. Finally, we
extrapolated ß for the 21st century to estimate the
future trends in H. pylori–associated DU and GC.
We set up the model with nine transmission
parameters, according to the age groups of
infected and susceptible persons. To find ßs in
mid-1800s, we assumed that the pattern of
infection in the United States at that time was
similar to that in developing countries today, i.e.,
rapid acquisition of H. pylori at younger ages (up
to 5 years old) and subsequent slower acquisition
rate, achieving a maximum prevalence of
approximately 80%. In personal interviews, four
experts in H. pylori epidemiology provided an
assessment of the transmissibility among
different age groups; they estimated transmis-
sion among children to be 5 to 10 times higher
than among adults (Hazell SL, Megraud F, Blaser
M, Correa P, unpub. comm.). No assessment could
be obtained for the different inter-age group
transmissions (ßCY, ßCA, ßYC, ßYA, ßAC, ßAY). For
the baseline analysis, we assumed that inter-age
group transmissions are negligible compared
with intra-age group transmissions (ßCC,  ßYY,
ßAA) because on average, interaction among
persons of the same age group is the highest.Emerging Infectious Diseases Vol. 6, No. 3, May–June 2000 232 232 232 232 232
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Figure 2. Temporal change in transmission param-
eters.  The transmissibility values in 1850 yielded a
pattern of infection similar to that observed in
developing countries today (rapid acquisition in
younger ages and lower acquisition in older ages). The
rapid decline of transmissibility in the latter half of
the 19th century is consistent with GC and DU
patterns. Although the graph does not show the
decrease in ßAA because of the scale (ßAA is much
smaller than ßCC and ßYY), ßAA also decreased over time.
Constant extrapolation of transmissibility assumes
no change in standards of living that would affect
H. pylori transmission.
This translated into Potential Transmission
Rates (PTR, defined as the average number of
secondary infections per unit of time that an
infected person would produce in an infection-
free population) of PTRCC = 0.6 for children (one
infected child would be expected to transmit the
pathogen to 0.6 susceptible child per year),
PTRYY = 0.25 for youths, and PTRAA = 0.15 for
adults. In real populations, these transmission
parameters would result in lower incidence rates,
since no population is infection free.
Change in Transmissibility from 1850 to 1995
We estimated the change in transmissibility
from 1850 to 1995 that was most consistent with
the historical trends of DU and GC and with
current H. pylori prevalence in the United States
(Figure 2). The fastest decrease occurred in the
latter half of the 19th century. Transmissibility
then leveled off at ßCC = 0.000042, ßYY = 0.0000044,
and ßAA = 0.0000009. Only a pronounced decrease
in ß at the end of the 19th century could explain
the decline in GC incidence and deaths observed.
Such a plateau in transmissibility was necessary
Once we established transmission param-
eters for the mid-1800s, we estimated changes in
transmissibility that could explain the historical
patterns of GC and DU. GC incidence and deaths
have been decreasing since the beginning of the
20th century (25,27,28). DU, however, is
characterized by a rise and fall within the 19th
century (29-31). For DU, long-term estimates
were based on other statistics, such as deaths,
physician visits, and hospitalized patients.
Investigators have postulated that the
different patterns of GC and DU could be
explained by a more rapid decline in childhood
than in adult incidence, thereby decreasing the
proportion of new infections acquired in
childhood (10,32). We evaluated whether changes
in  ß consistent with this hypothesis could
reasonably explain disease patterns. We then
extrapolated the transmissibility values into the
year 2100 on the basis of our projections for
future socioeconomic changes that would affect
the dynamics of H. pylori transmission, and
estimated the future trends in H. pylori
prevalence, as well as the incidence of H. pylori–
associated GC and DU.
Model Implementation
We implemented the model using the
software package Powersim Constructor Version
2.5 (Powersim Corp., Herndon, VA), integrated
with Microsoft Excel 97 (Microsoft Corp.,
Redmond, VA). We set Powersim to use Runge-
Kutta 4th-order integration method and time-
step of 1 year.
To obtain correct flows of age groups, at the
implementation level we further subdivided the
child and youth groups by 1-year age increments
(i.e., birth through first birthday, 1 year of age
through second birthday . . .  14 years of age
through 15th birthday). We subdivided the adult
compartments by 5-year age increments up to 85
years of age (15 years of age through 20th
birthday . . . 80 years of age through 85th
birthday, 85+), which allowed us to program the
age-specific death rate and track the aging of
cohorts with relative accuracy.
Results
Transmissibility of H. pylori in 1850
The values of transmissibility most consistent
with the endemic pattern of infection were: ßCC =
0.000055, ßYY = 0.000011, and ßAA = 0.0000012.Vol. 6, No. 3, May–June 2000 Emerging Infectious Diseases 233 233 233 233 233
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Figure 3. Simulated temporal change in Helicobacter
pylori and associated diseases.  a) Prevalence of
H. pylori in the U.S. population by age category
(simulation output). b) Incidence of DU and GC per
100,000 U.S. population. “Hp GC” and “Hp DU” are
simulation outputs. “SEER GC” represents incidence
of GC from all cases, from the Surveillance,
Epidemiology, and End Results report (25). “NCHS
GC” represents incidence of GC from all cases, derived
from the mortality statistics published by the
National Center for Health Statistics and the Bureau
of the Census (28). “Kurata et al. DU” represents
incidence of DU from all cases, based on data from a
large health maintenance organization in southern
California (34). The simulation model predicted that
the prevalence of H. pylori, as well as incidence of
H. pylori-associated DU and GC, would continue to
decrease in the 21st century.
GC = gastric cancer; DU = duodenal ulcer; NCHS = National
Center for Health Statistics; SEER = Surveillance,
Epidemiology, and End Results system.
1Specific graphs can be made available to readers upon request.
A
B
for the prevalence of H. pylori infection to coincide
with current rates. An S-shaped Gompertz curve
(33)—in which the decrease is slow initially,
accelerates, and slows down again, trending to a
stable level—best illustrates the past trends in
H. pylori and associated DU and GC.
H. pylori Prevalence, DU Incidence, and GC
Incidence
We simulated the temporal trend of H. pylori
prevalence in the general U.S. population by age
category (Figure 3a). Among children, prevalence
decreased from 30% in 1850 to 1% by the end of
the 20th century; among youths, prevalence
decreased from approximately 70% to 5%, and
among adults, from approximately 80% to less
than 20% in the same period. We compared the
simulation outputs with available U.S. data on
incidence of GC and DU (Figure 3b). According to
the two sources on GC incidence and deaths
(25,28), total GC incidence declined from approxi-
mately 34 per 100,000 in 1930 to 6.6 per 100,000 in
1995. In comparison, H. pylori-associated GC,
estimated from the simulation, decreased from 24
per 100,000 in 1930 to 5.8 per 100,000 in 1995.
Kurata and colleagues, based on data from a large
health-maintenance organization in southern
California from 1977 to 1980, estimated the
incidence of DU to be 58 per 100,000 (34). In
comparison, our model estimated H. pylori-asso-
ciated DU incidence to be 47 per 100,000 in 1980.
To extend the simulation through 2100, we
assumed that the transmissibility of H. pylori
would remain stable at the level in 1995
(Figure 2) and kept the input parameters
constant.  H. pylori prevalence, as well as the
associated DU and GC, would continue to
decrease in the 21st century. By 2100, the model
predicted incidences of 1.3 and 12.2 per 100,000
population for H. pylori-associated DU and GC,
respectively, with overall H. pylori prevalence
decreasing to 4.2%.
Sensitivity Analyses
We tested the model by using different input
assumptions. For each change in the input
assumptions, we generated curves of H. pylori
prevalence and incidences of H. pylori-associated
GC and DU.1 The most sensitive variables were
the proportion of persons with antrum- (vs.Emerging Infectious Diseases Vol. 6, No. 3, May–June 2000 234 234 234 234 234
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corpus-) predominant gastritis, rate of progres-
sion from AG to DU, and rate of progression from
CAG to GC. For example, when the rate of
progression from CAG to GC was 0.0035, the
incidence of H. pylori-associated GC decreased
from 6.7 per 100,000 in 1995 to 1.5 per 100,000 in
2100; when the rate was assumed to be 0.0025,
the incidence in 1995 was 4.9 per 100,000,
decreasing to 1.1 per 100,000 by the end of the
21st century. Overall, we found that H. pylori
prevalence would decrease to <10% in the general
U.S. population and the incidence of H. pylori-
associated DU and GC would decrease to <20 and
1.5 per 100,000 population, respectively, by the
end of the 21st century.
Discussion
This work provides insights into the intrinsic
dynamics of H. pylori and associated diseases,
applying and extending the basic principles of
mathematical modeling used extensively in
infectious disease analysis. First, we found that
in the United States, transmissibility of H. pylori
has already become so low that the incidence and
prevalence of the organism will continuously
decrease in the foreseeable future, without any
targeted intervention. The disappearance of
H. pylori, however, would take more than a
century without intervention. Second, we found
that only a rapid decline in H. pylori
transmissibility during the second half of the
19th century could explain the rapid decrease in
GC incidence observed in the 20th century. We
tested different curves of decrease in H. pylori
transmissibility and found that a Gompertz curve
best fits the past trends of H. pylori and
associated GC and DU. Gompertz curves have
been used to describe decline of living organisms,
as well as mechanical devices (33). Our findings
suggest that those curves could also be used to
represent waning of transmissibility (infectivity
or transmission potential) of an organism in a
given host population.
The decline in transmissibility paralleled the
rapid improvement in sanitation and hygiene
that occurred in the 19th and early 20th centuries
in the United States. In a history of hygiene in the
United States, Hoy describes how the United
States, once a country with poor sanitary
conditions, became one with exemplary cleanli-
ness (35). The author states that “in 1850,
cleanliness in the United States, north and south,
rural and urban, stood at Third World levels.”
During the Civil War era, appreciation for
cleanliness expanded. Frequent washing of
clothes and bathing with soap, expanded
availability of clean running water, and
development of a sewage network in the late 19th
century were among improvements in personal
hygiene. Although we cannot rule out other
causes, this massive improvement in sanitary
and hygienic conditions (better household
hygiene and community sanitation projects,
including water purification systems), which was
responsible for reducing the incidence of
infectious diseases such as shigellosis and
typhoid, could also explain the decrease in
transmissibility of H. pylori.
This model attempted to explain quantita-
tively how the shift in age of H. pylori acquisition
could have produced the different patterns of DU
and GC outcomes. We cannot rule out other
factors (such as change in H. pylori strains), not
included in our model, which could have been
responsible for the rise and fall of DU and the
parallel decrease in GC.
We can indirectly estimate H. pylori–
associated GC from National Center for Health
Statistics (NCHS) and Surveillance, Epidemiol-
ogy, and End Results (SEER) curves showing GC
incidence from all cases, based on attributable
risk (Figure 3b). Since attributable risk for
H. pylori is believed to have decreased because
the proportion of proximal GC is higher today
than it was at the beginning of the 20th century,
the total GC curve underestimates the decline in
H. pylori-associated GC. Thus, the incidence of
H. pylori-associated GC from our simulation is
higher than the one estimated by the method of
attributable risk applied to NCHS/SEER data.
This discrepancy can be explained by the
existence of other factors acting in conjunction
with H. pylori to promote the development of GC.
The discrepancy, however, does not affect our
conclusions about future decreasing trends in
H. pylori and associated diseases.
In this study, we did not model the
demographic changes—such as increase in birth
rate and life expectancy—that occurred in the
United States from 1850 to the present.
Demographic changes affect the epidemiology
and disease statistics in many ways. For
example, an increase in birth rate would affect
population density and crowding, depending on
availability of land. Change in the size of a family
unit could also affect the transmission dynamics.Vol. 6, No. 3, May–June 2000 Emerging Infectious Diseases 235 235 235 235 235
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The model quickly becomes too complex and
intractable. We therefore fixed the population
parameters as in other infectious disease
transmission models (8,36,37). Because our
simulation covers a long time span (1850 to 2100),
to compromise between the past, present, and
future, we derived the population characteristics
from the demographic data of 1950. In sensitivity
analyses, we also tested different birth and death
rates, but the predictions for future H. pylori
prevalence and incidence of H. pylori-associ-
ated DU and GC did not differ significantly
from the base case.
In our baseline model, we assumed that 20%
of the population would not become infected with
H. pylori. This is based on studies from
developing countries, where prevalence in older
adults is typically 70% to 90%. Given the high
rates of transmission in childhood required to
account for this high endemicity, the prevalence
of nonsusceptible persons (because they are
either immune or physically isolated) is critical in
explaining why 100% prevalence has not been
observed in any population. The model, however,
can accommodate a range of values, including
100% prevalence.
We simplified the quantification of transmis-
sion parameters by considering only transmis-
sion between persons in the same age group. In
reality, transmission can also occur between
adults and children or adults and youths.
However, no data are available on the magnitude
of transmission between or among different age
groups. Therefore, we also tested the model by
using positive numbers for inter-age group
transmission, but the predictions for future
H. pylori prevalence and incidence of associated
GC and DU did not differ significantly from our
base case results.
Given the model estimation that H. pylori
transmissibility has remained relatively con-
stant since the beginning of 20th century, despite
many recent developments and changes in life-
style, we assumed that maintenance of the
current  H. pylori transmissibility would be a
reasonable extrapolation for the next century.
Despite this assumption of constant transmissi-
bility, the model predicted that H. pylori
prevalence, as well as H. pylori-associated DU
and GC, would continue to decrease without
intervention. Thus, the decreasing trends
indicate that transmissibility of H. pylori has
already declined below the threshold value
needed to maintain the organism endemic in the
population. Without any targeted intervention,
however, the disappearance of H. pylori from the
U.S. population will take more than a century.
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